Edition:
India

Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.89USD
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
$3.89
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
35,313
52-wk High
$4.30
52-wk Low
$2.00

Latest Key Developments (Source: Significant Developments)

Compugen Ltd Files For Mixed Shelf Of Upto $200 Million
Monday, 5 Aug 2019 

Aug 5 (Reuters) - Compugen Ltd ::COMPUGEN LTD FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING.  Full Article

Compugen Q2 Loss Per Share $0.10
Monday, 5 Aug 2019 

Compugen Ltd ::COMPUGEN REPORTS SECOND QUARTER 2019 RESULTS.Q2 LOSS PER SHARE $0.10.AS OF JUNE 30, 2019, CASH, CASH RELATED ACCOUNTS, SHORT-TERM AND LONG-TERM BANK DEPOSITS TOTALED $37.0 MILLION.  Full Article

Compugen Announces Exclusive License Agreement With Medimmune
Monday, 2 Apr 2018 

April 2 (Reuters) - Compugen Ltd ::SPECIFIC ANTIBODY PRODUCTS‍​.SEC FILING.CO ALSO ELIGIBLE TO RECEIVE UP TO $200 MILLION IN DEVELOPMENT, REGULATORY, COMMERCIAL MILESTONES ON FUTURE PRODUCT SALES.  Full Article

Compugen Reports Q4 Loss Per Share Of $0.18
Wednesday, 21 Feb 2018 

Feb 21 (Reuters) - Compugen Ltd ::COMPUGEN REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 LOSS PER SHARE $0.18.COMPUGEN - AS OF DEC 31, 2017, CASH, CASH RELATED ACCOUNTS, SHORT-TERM AND LONG-TERM BANK DEPOSITS TOTALED $30.4 MILLION, COMPARED WITH $61.5 MILLION LAST YEAR.  Full Article

COMPUGEN REPORTS Q3 LOSS PER SHARE $0.19
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Compugen Ltd ::COMPUGEN REPORTS THIRD QUARTER 2017 RESULTS.Q3 LOSS PER SHARE $0.19.‍AS OF SEPTEMBER 30, 2017, CASH AND CASH RELATED ACCOUNTS TOTALED $38.5 MILLION, COMPARED WITH $61.5 MILLION AS OF DECEMBER 31, 2016​.  Full Article

Compugen to initiate manufacturing of COM902
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Compugen Ltd :Compugen Ltd - ‍advancing COM902 into manufacturing in anticipation of filing an investigational new drug (IND) application in 2019​.Compugen Ltd - ‍entered into process development and manufacturing service agreement with Bayer Healthcare LLC (Bayer) to produce COM902.Compugen Ltd - ‍working towards filing IND for COM902 in 2019​.  Full Article